Abstract
Herein we report the use of next generation maleimides (NGMs) for the construction of a potent antibody-drug conjugate (ADC) via functional disulfide bridging. The linker has excellent stability in blood serum and the ADC, armed with monomethyl auristatin E (MMAE), shows excellent potency and cancer cell selectivity in vitro. This journal is
Cite
CITATION STYLE
Nunes, J. P. M., Morais, M., Vassileva, V., Robinson, E., Rajkumar, V. S., Smith, M. E. B., … Chudasama, V. (2015). Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody-drug conjugate (ADC). Chemical Communications, 51(53), 10624–10627. https://doi.org/10.1039/c5cc03557k
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.